Perilesional branch duct dilation as a hallmark MRCP feature for differentiating high-grade PanIN from low-grade PanIN
Pancreatology · 2025
DOI: 10.1016/j.pan.2025.06.003 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pancreatology, 2025. Verfasst von Kentaro Yamao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan; Pancreatic Cancer Research for Secure Sa…. Hauptthemen laut MEDLINE: Cholangiopancreatography, Magnetic Resonance, Pancreatic Ducts, Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
BACKGROUND/OBJECTIVES: Pancreatic cancer (PC) is frequently diagnosed at an advanced stage with a poor prognosis. Early detection of high-grade pancreatic intraepithelial neoplasia (HG-PanIN), a stage 0 lesion, has the potential to significantly improve patient outcomes. This study aimed to identify specific imaging findings on magnetic resonance cholangiopancreatography (MRCP) and magnetic resonance imaging (MRI) that distinguish HG-PanIN from low-grade PanIN (LG-PanIN). METHODS: This multicenter retrospective study included 57 patients with pathologically confirmed PanIN (41 HG-PanIN, 16 LG-PanIN). MRCP and MRI images were independently reviewed by two experienced abdominal radiologists. Sensitivity, specificity, diagnostic accuracy, and interobserver agreement (kappa (κ) coefficient) were calculated. Multivariate logistic regression analysis identified independent predictors of HG-PanIN. RESULTS: On MRCP, perilesional branch pancreatic duct (BPD) dilation emerged as a promising imaging marker for distinguishing HG-PanIN, alongside substantial interobserver agreement (κ = 0.64). Pancreatic parenchymal atrophy (PPA) also exhibited diagnostic potential but were limited by lower reproducibility (κ = 0.23). Multivariate analysis identified both perilesional BPD dilation (OR 24.62; 95 % CI 2.66-227.86; p < 0.01) and PPA (OR 37.21; 95 % CI 3.97-348.92; p < 0.01) as independent predictors of HG-PanIN. In subgroup analyses, combining BPD dilation with PPA significantly enhanced specificity for early lesion detection. CONCLUSIONS: Perilesional BPD dilation on MRCP is a primary imaging feature for differentiating HG-PanIN, characterized by substantial interobserver agreement. While PPA on MRI is another important independent predictor, its lower interobserver agreement warrants caution. These findings highlight the diagnostic value of utilizing both MRCP and MRI in the noninvasive evaluation of suspected PanIN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan; Pancreatic Cancer Research for Secure Salvage Young Investigators (PASSYON), Osaka-Sayama, Osaka, Japan. Elect…
- Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- Department of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital, Tokyo, Japan; Pancreatic Cancer Research for Secure Salvage Young Investigators (PASSYON), Osaka-Sayama, Osaka,…
- Department of Gastroenterology, Tenri Hospital, Nara, Japan; Pancreatic Cancer Research for Secure Salvage Young Investigators (PASSYON), Osaka-Sayama, Osaka, Japan.
- Department of Gastroenterology, Faculty of Medicine, Oita University, Oita, Japan; Pancreatic Cancer Research for Secure Salvage Young Investigators (PASSYON), Osaka-Sayama, Osaka, Japan.
- Department of Gastroenterology, Oita San-ai Medical Center, Oita, Japan.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Yamao, K., Takehara, Y., Ogawa, H., Nakahodo, J., Minami, R., Sagami, R., Nishikiori, H., Okita, M., Takahashi, H., Takada, Y., Uetsuki, K., Iida, T., Mizutani, Y., Ishikawa, T., & Kawashima, H. (2025). Perilesional branch duct dilation as a hallmark MRCP feature for differentiating high-grade PanIN from low-grade PanIN. Pancreatology. https://doi.org/10.1016/j.pan.2025.06.003
Vancouver
Yamao K, Takehara Y, Ogawa H, Nakahodo J, Minami R, Sagami R, et al. Perilesional branch duct dilation as a hallmark MRCP feature for differentiating high-grade PanIN from low-grade PanIN. Pancreatology. 2025. doi:10.1016/j.pan.2025.06.003
BibTeX
@article{Yamao2025,
author = {Yamao, Kentaro and Takehara, Yasuo and Ogawa, Hiroshi and Nakahodo, Jun and Minami, Ryuki and Sagami, Ryota and Nishikiori, Hidefumi and Okita, Muneyori and Takahashi, Hidekazu and Takada, Yoshihisa and Uetsuki, Kota and Iida, Tadashi and Mizutani, Yasuyuki and Ishikawa, Takuya and Kawashima, Hiroki},
title = {Perilesional branch duct dilation as a hallmark MRCP feature for differentiating high-grade PanIN from low-grade PanIN},
journal = {Pancreatology},
year = {2025},
doi = {10.1016/j.pan.2025.06.003}
}
EUVIMED